SlideShare a Scribd company logo
Measures Of Morbidity
- Ravi Prakash Verma
M.A. /M.Sc. 1st year
kriparavi@yahoo.com
International Institute for Population Sciences, Mumbai.
The study of Morbidity deals with the investigation of illness, sickness, ill-health or
disease in a population .
-Multilingual Demographic Dictionary
Morbidity is a extent of illness (disease), injury, or disability in a defined population.
-J. B. Stallman
Morbidity
Measures of Morbidity
The WHO expert committee on Health Statistics noted in its 6th report that
morbidity could be measured in terms of three units:
a) Person who were ill.
b) The illness (Periods /spells/illness) that diseased person experience.
c) The duration of these illness .
Source –WHO(1959)
Illness Exist in a given Time Period as follows;
 Illness beginning during the period and ending during the period.
 Illness beginning during the period and still existing at the end of the period
 Illnesses existing before the beginning of the period and ending during the period
 Illnesses existing before the beginning of the period and existing at the end of the period (Prakasam
2017)
Illness :Time Period
Disease , Illness or Sickness is measured by calculating;
 Incidence Rate
 Prevalence Rate: Period Prevalence Rate, Point Prevalence Rate
 Attack Rate , Secondary Attack Rate
 Case Fatality Rate
 Duration Of illness / Sickness
 Relative Risk , Attributable Risk and Odds Ratio
Other measures:
o Disability Rate
o HALE
o QALY
o DFLE
o DALY
Measures:
Incidence Rate is given by the following equation:
Number of new cases of specific,
Incidence rate (IR) =
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒏𝒆𝒘 𝒄𝒂𝒔𝒆𝒔 𝒐𝒇 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒄 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝒅𝒖𝒓𝒊𝒏𝒈 𝒂 𝒈𝒊𝒗𝒆𝒏 𝒕𝒊𝒎𝒆 𝒑𝒆𝒓𝒊𝒐𝒅
𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒂𝒕 𝒓𝒊𝒔𝒌 𝒅𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒂𝒕 𝒑𝒆𝒓𝒊𝒐𝒅
× 𝟏𝟎𝟎𝟎
This measure is also discussed in the module on concepts of health.
INCIDENT RATE
Point Prevalence =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝑐𝑎𝑠𝑒𝑠 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑎𝑡 𝑎 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑠𝑎𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒
Period Prevalence Rate =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝑐𝑎𝑠𝑒𝑠 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑎𝑡 𝑎 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑠𝑎𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒
PREVALENCE RATE
Case 1
Case 2 Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
start of illness
duration of illness
Jan 1 Dec 31
Incidence would be –
Point prevalence (Jan 1) –
Point prevalence (Dec 31) –
Period prevalence (Jan-Dec) –
cases 3, 4, 5 and 8
cases 1, 2, 7
cases 1, 3, 5 and 8
cases 1, 2, 3, 4, 5, 7, 8
𝑷
(𝟏−𝑷)
=I× 𝑫
Where,
P = Proportion of total population with the disease and I is Incidence rate
1-P = Proportion of the total population without the disease
In situations where the number of persons with the disease in a population and without the disease are stable, then it
is referred to as a steady-state population. In such situations, the point prevalence of the disease (prevalence of the
disease at a particular point of time) is approximately equal to the incidence rate X the average duration of the disease.
P=I× 𝑫
Relationship between Prevalence and Incident
The attack rate the number of new cases of a particular disease during a particular time interval, to the total
population at risk of that particular disease in the same period of time, multiplied by 100. It is given by the equation:
Attack rate=
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒏𝒆𝒘 𝒄𝒂𝒔𝒆𝒔 𝒐𝒇 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒆𝒅 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 𝒅𝒖𝒓𝒊𝒏𝒈 𝒊𝒕𝒔 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒆𝒅 𝒕𝒊𝒎𝒆 𝒊𝒏𝒕𝒆𝒓𝒗𝒂𝒍
𝑻𝒐𝒕𝒂𝒍 𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒂𝒕 𝒓𝒊𝒔𝒌 𝒅𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒆 𝒔𝒂𝒎𝒆 𝒊𝒏𝒕𝒆𝒓𝒗𝒂𝒍
× 𝟏𝟎𝟎
ATTACK RATE
The number of exposed persons developing the disease within the range of the incubation period, following
exposure to the primary case” (GOI 2015).
The attack rate is based on spells of the disease rather than persons. It is generally used for infections of short
period of time as during an epidemic. It usually measures the spread of the infection after exposure to an initial
case (Indrayan N.D.).
The secondary attack rate is the number of exposed persons developing the disease within the range of the
incubation period to the total number of exposed to susceptible contact, multiplied by 100.
Secondary Attack Rate =
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒆𝒙𝒑𝒐𝒔𝒆𝒅 𝒑𝒆𝒓𝒔𝒐𝒏𝒔 𝒅𝒆𝒗𝒍𝒐𝒑𝒊𝒏𝒈 𝒕𝒉𝒆 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 𝒘𝒊𝒕𝒉𝒊𝒏 𝒕𝒉𝒆 𝒓𝒂𝒏𝒈𝒆 𝒐𝒇 𝒕𝒉𝒆 𝒊𝒏𝒄𝒖𝒃𝒂𝒕𝒊𝒐𝒏 𝒑𝒆𝒓𝒊𝒐𝒅
𝑻𝒐𝒕𝒂𝒍 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒆𝒙𝒑𝒐𝒔𝒆𝒅 𝒔𝒖𝒔𝒄𝒆𝒑𝒕𝒊𝒃𝒍𝒆 𝒄𝒐𝒏𝒕𝒂𝒄𝒕
×100
Secondary Attack Rate
The duration of illness can be calculated in terms of the average duration of illness per person, per person sick, or spell,
and these are expressed by the following equations:
Average duration of illness per Person =
𝑻𝒐𝒕𝒂𝒍 𝒅𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔
𝑻𝒐𝒕𝒂𝒍 𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒆𝒙𝒑𝒐𝒔𝒆𝒅
Average duration of illness per person sick =
𝑻𝒐𝒕𝒂𝒍 𝑫𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 𝒐𝒇 𝒔𝒊𝒄𝒌 𝒑𝒆𝒓𝒔𝒐𝒏𝒔
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒑𝒆𝒓𝒔𝒐𝒏𝒔 𝒇𝒆𝒍𝒍 𝒊𝒍𝒍
Average duration of illness Per Spell =
𝑻𝒐𝒕𝒂𝒍 𝒅𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 𝒐𝒇 𝒂𝒍𝒍 𝒔𝒊𝒄𝒌 𝒑𝒆𝒓𝒔𝒐𝒏
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒔𝒑𝒆𝒍𝒍 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔
Duration Of ILLNESS
RR =
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 (𝑜𝑟 𝑑𝑒𝑎𝑡ℎ) 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 (𝑜𝑟 𝑑𝑒𝑎𝑡ℎ) 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛−𝑒𝑥𝑝𝑜𝑠𝑒𝑑
An example of using the Relative Risk, is with a measure of the association between Cancer and smoking. It is given in
the table below, wherein those who smoke cigarettes are compared with those who do not smoke cigarettes, in
relation to having developed cancer,
Relative Risk of those who smoke to get cancer= (a/a+b)
= Those who smoke who developed cancer/ the total persons who smoke
= 80/4000 x 1000= 2.0
Relative Risk of those who do not smoke to get cancer= (c/c + d )
= Those who do not smoke who developed cancer/ the total number of persons who do not smoke
. =6/5000 x 1000= 1.2
Relative Risk (cigarette smoking causes cancer) = (a/a+b) / (c/c + d) = 2.0/1.2 = 1.67
Cigarette Smoking Developed Cancer Not Cancer Total
Yes 80(a) 3200(b) 4000( a+b )
NO 6(c) 4994(d) 5000( c+d )
Relative Risk
 Relative risk (RR) is a ratio. It directly measures the strength
of association between the studied cause and the effect .
 If the RR ratio is more than 1, then it suggests a “positive”
association.
In recent times, there has been no marked change in death rates, and as a result, disability rates as with regard to
illness and injury have come to be used in order to supplement the mortality and morbidity indicators.
There are two common groups of indicators of disability rates:
a) Event type indicators, and
b) person type indicators.
a) Event-type indicators:
 Number of days of restricted activity
 Bed disability days
 Work-loss days (or school-loss days) within a specified period
b) Person-type indicators
 Limitation of mobility: Confined to bed, Confine to house
 Limitation of activity: Limitation to perform the basic activities of daily living (ADL)- e.g.: eating, washing,
dressing, going to toilet, moving around , limitation of doing specific job (Prakasam 2017).
Disability Rates:
HALE stands for health-adjusted life expectancy. It is based on what was previously the disability-adjusted life expectancy
(DALE), changed in order to represent all states of health.
The HALE measure is based on life expectancy at birth but is includes an adjustment for time of life spent in poor health.
HALE is based on life expectancy at birth but includes an adjustment for time spent in poor health.
HALE is the number of years in full health that a newborn can expected to live based on current rate of ill-health and
mortality (WHO 2002).
HALE is defined as , “ Average number of years that a person can expect to live in "full health" by taking into account
years lived in less than full health due to disease and/or injury.” (WHO 2017).
The measure takes into account different measures of population health, and it is adjusted for severity distribution, and
is sensitive to changes over time and to differences across countries in severity in state of health (WHO 2017).
Health-Adjusted Life Expectancy (HALE):
QALY or Quality-adjusted life years measures the burden of disease including both quantity of live lives as well as
the quality of life lived. It is used to assess a medical intervention in terms of value for money.
QALY is thus based on estimating the “number of years of life that would have been lived with perfect life with the
medical intervention” (Prieto et.al. 2003).
In other words, it can be said to be an indicator that assesses both the quantity and quality of life in the health of
a population. Therefore, an extension of life expectancy can also be measured in terms of whether they are years
of healthy life.
One example is that a person may be taking an intervention to address the problem of hypertension for about 3
decades, which adds a decade more to his life, at a slightly reduced level of quality. He would also need further
intervention, which reduces his quality of life further by a given amount. The QALY would then be calculated to
see how many years in total would be gained – say, around 8 years after adjusting above. There are many other
ways in which QALYs can be applied (uOttawa 2014)
Quality-adjusted life years (QALY):
There are a few basic facts to DALY mentioned below:
1. DALYs were first reported in the World Development report in 1993
2. DALYs are a new composite indicator of population health status and express the burden of morbidity and mortality.
3. DALYs were designed with cost-effectiveness analysis in mind.
DALY measures overall disease burden. It is expressed as the number of years lost due to ill-health, disability or early
death. The measure enables capturing the impact of both important fatal and non-fatal disabling conditions on a
population. The DALY combines two measures, the Years of Lost Life (YLL) and Years Lost to Disability (YLD) as:
---Years of lost life (YLL):
This measure is calculated from the number of deaths occurring at each age, which is multiplied by the expected
remaining years of life, according to a global standard of life expectancy.
𝑌𝐿𝐿 = 𝑁 × 𝐿
Where,
N=Number of deaths;
L= Standard life expectancy at age of death in year
DALY: Basic facts;
This measure is calculated as the number of incident cases of disability due to injury and illness, multiplied by
the average duration of the disease and a weighting factor which reflects disease severity on a scale from 0
(perfect health) to 1 (dead) (Prakasam 2017)
YLD=𝐼 × 𝐷𝑊 × 𝐿.
Where, I= Number of incidence cases
DW = Disability Weight
L= average duration of the case until remission or death (years)
DALY=𝑌𝐿𝐿 + 𝑌𝐿𝐷
---Years lost to disability (YLD):
 Disability-free life expectancy (DFLE) is the average number of years an individual is
expected to live free of disability if the current pattern of mortality and disability
continues to apply.
 The DFLE indicator has been developed and used in many countries since the 1970s.
 The definition is a derivation from statistical sources of organizations as the IMF and
OECD. As per the OECD, can be considered in terms of functional limitation-free life
expectancy, and activity restriction-free life expectancy (OECD 2003).
Disability-free life expectancy (DFLE);
Reproductive Morbidity :
Apart from the above rates, in the recent period morbidity related to pregnancy and contraception is measured under
Reproductive morbidity.
Reproductive morbidity:
Reproductive morbidities are morbidities that occur during pregnancy, during childbirth or within a period of 42 days of
giving birth (Prakasam 2017).
WHO (1990) has defined reproductive morbidity broadly as:
“any morbidity or dysfunction of the reproductive tract or any morbidity which is a consequence of reproductive
behavior including pregnancy, abortion, childbirth or sexual behavior. Morbidities may include those of a psychological
nature”
The WHO has spelled reproductive morbidity as consisting of three types of morbidity:
1. Obstetric,
2. Gynecological and
3. contraceptive morbidity.
Obstetric morbidity:
Morbidity in a women who has been pregnant (regardless of the duration of pregnancy) from any cause related to
or aggravated by the pregnancy or its management, but not from accidental or incidental causes.
Gynecological morbidity:
includes any condition, disease or dysfunction of the reproductive system, which is not related to pregnancy,
abortion, or childbirth but may be related to sexual behavior.
Contraceptive Morbidity:
Contraceptive morbidity includes condition, which result from efforts (other than abortion) to limit family size,
whether they are traditional or modern methods” (WHO 1990).
 http://www.worldbank.org/html/extdr/hnp/hdddlash/worksp/we_00068.html
 http://www.un.org/esa/socdev/enable/dis50y10.htm
 http://www.who.int/healthinfo/globalburdendisease/metrics_daly/en/
 https://stats.oecd.org/glossary/detail.asp?ID=632
 http://mospiold.nic.in/Mospi_New/upload/Manual-Health-Statistics_5june15.pdf
 https://books.google.co.in/books?id=GQEdA
References

More Related Content

What's hot

Standardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil TumainiStandardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil Tumaini
Basil Tumaini
 
DALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurungDALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurung
Samrat Gurung
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
Miharbi Ignasm
 
investigation of an epidemic
investigation of an epidemicinvestigation of an epidemic
investigation of an epidemic
Bala Vidyadhar
 
Epidemiological Transition
Epidemiological TransitionEpidemiological Transition
Epidemiological Transition
kdjw
 
Ecological study
Ecological studyEcological study
Ecological study
Nik Ronaidi
 
Cluster randomization trial presentation
Cluster randomization trial presentationCluster randomization trial presentation
Cluster randomization trial presentation
Ranadip Chowdhury
 
Attributable risk and population attributable risk
Attributable risk and population attributable riskAttributable risk and population attributable risk
Attributable risk and population attributable risk
Abino David
 
Association and causation
Association and causationAssociation and causation
Association and causation
drravimr
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
Palwasha Khan
 
Attack rate
Attack rateAttack rate
Attack rate
sonytopp
 
2 measurements in epidemiology(1)
2  measurements in epidemiology(1)2  measurements in epidemiology(1)
2 measurements in epidemiology(1)
Raad Saeed Altaee
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
Krupa Mathew
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
Dr Venkatesh Karthikeyan
 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to Epidemiology
Aya Mohamed
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Mohammad Ismail Zubair MD. MSc
 
Disability Adjusted Life Years
Disability Adjusted Life YearsDisability Adjusted Life Years
Disability Adjusted Life Years
Abdur Razzaque Sarker, PhD
 
Clinical Epidemiology.pptx
Clinical Epidemiology.pptxClinical Epidemiology.pptx
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
A M
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
Rizwan S A
 

What's hot (20)

Standardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil TumainiStandardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil Tumaini
 
DALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurungDALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurung
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
 
investigation of an epidemic
investigation of an epidemicinvestigation of an epidemic
investigation of an epidemic
 
Epidemiological Transition
Epidemiological TransitionEpidemiological Transition
Epidemiological Transition
 
Ecological study
Ecological studyEcological study
Ecological study
 
Cluster randomization trial presentation
Cluster randomization trial presentationCluster randomization trial presentation
Cluster randomization trial presentation
 
Attributable risk and population attributable risk
Attributable risk and population attributable riskAttributable risk and population attributable risk
Attributable risk and population attributable risk
 
Association and causation
Association and causationAssociation and causation
Association and causation
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
 
Attack rate
Attack rateAttack rate
Attack rate
 
2 measurements in epidemiology(1)
2  measurements in epidemiology(1)2  measurements in epidemiology(1)
2 measurements in epidemiology(1)
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to Epidemiology
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Disability Adjusted Life Years
Disability Adjusted Life YearsDisability Adjusted Life Years
Disability Adjusted Life Years
 
Clinical Epidemiology.pptx
Clinical Epidemiology.pptxClinical Epidemiology.pptx
Clinical Epidemiology.pptx
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
 
Basic measurements in epidemiology
Basic measurements in epidemiologyBasic measurements in epidemiology
Basic measurements in epidemiology
 

Similar to Measures Of Morbidity

Epidemiological concepts english
Epidemiological concepts   englishEpidemiological concepts   english
Epidemiological concepts english
MY STUDENT SUPPORT SYSTEM .
 
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptxTopic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
kihembopamelah
 
Statistical epidemiology
Statistical  epidemiologyStatistical  epidemiology
Statistical epidemiology
Nandhini Sekar
 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptx
DeepakRx1
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
mhosn627
 
statistical methods in epidemiology.pptx
statistical methods in epidemiology.pptxstatistical methods in epidemiology.pptx
statistical methods in epidemiology.pptx
Anusha Are
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
MunnajiMavatkar
 
Ozz(morbidity and mortality)
Ozz(morbidity and mortality)Ozz(morbidity and mortality)
Ozz(morbidity and mortality)
Viju Rathod
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
Drsadhana Meena
 
Morbidity and mortality slides
Morbidity and mortality slidesMorbidity and mortality slides
Morbidity and mortality slides
jesus4u
 
2.Measurements.pdf
2.Measurements.pdf2.Measurements.pdf
2.Measurements.pdf
AMANUELMELAKU5
 
Epidemiology for nursing student
Epidemiology for nursing studentEpidemiology for nursing student
Epidemiology for nursing student
Patel Dharmendra
 
EPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILEDEPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILED
MAHESWARI JAIKUMAR
 
EPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILEDEPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILED
MAHESWARI JAIKUMAR
 
Understanding epidemiology study in medical statistics
Understanding epidemiology study in medical statisticsUnderstanding epidemiology study in medical statistics
Understanding epidemiology study in medical statistics
Laud Randy Amofah
 
Modern epidemiology
Modern epidemiologyModern epidemiology
Modern epidemiology
UE
 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptx
Emmanuel Ali Adamu
 
Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine
Dr.Farhana Yasmin
 
Statistical methods in epidemiology.ppt
Statistical methods in epidemiology.pptStatistical methods in epidemiology.ppt
Statistical methods in epidemiology.ppt
Ravinandan A P
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
mlogaraj
 

Similar to Measures Of Morbidity (20)

Epidemiological concepts english
Epidemiological concepts   englishEpidemiological concepts   english
Epidemiological concepts english
 
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptxTopic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
 
Statistical epidemiology
Statistical  epidemiologyStatistical  epidemiology
Statistical epidemiology
 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptx
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 
statistical methods in epidemiology.pptx
statistical methods in epidemiology.pptxstatistical methods in epidemiology.pptx
statistical methods in epidemiology.pptx
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
 
Ozz(morbidity and mortality)
Ozz(morbidity and mortality)Ozz(morbidity and mortality)
Ozz(morbidity and mortality)
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
 
Morbidity and mortality slides
Morbidity and mortality slidesMorbidity and mortality slides
Morbidity and mortality slides
 
2.Measurements.pdf
2.Measurements.pdf2.Measurements.pdf
2.Measurements.pdf
 
Epidemiology for nursing student
Epidemiology for nursing studentEpidemiology for nursing student
Epidemiology for nursing student
 
EPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILEDEPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILED
 
EPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILEDEPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILED
 
Understanding epidemiology study in medical statistics
Understanding epidemiology study in medical statisticsUnderstanding epidemiology study in medical statistics
Understanding epidemiology study in medical statistics
 
Modern epidemiology
Modern epidemiologyModern epidemiology
Modern epidemiology
 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptx
 
Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine
 
Statistical methods in epidemiology.ppt
Statistical methods in epidemiology.pptStatistical methods in epidemiology.ppt
Statistical methods in epidemiology.ppt
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 

Recently uploaded

Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
SHAMIN EABENSON
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Dr. David Greene Arizona
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
Lift Ability
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx Program
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 

Recently uploaded (20)

Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 

Measures Of Morbidity

  • 1. Measures Of Morbidity - Ravi Prakash Verma M.A. /M.Sc. 1st year kriparavi@yahoo.com International Institute for Population Sciences, Mumbai.
  • 2. The study of Morbidity deals with the investigation of illness, sickness, ill-health or disease in a population . -Multilingual Demographic Dictionary Morbidity is a extent of illness (disease), injury, or disability in a defined population. -J. B. Stallman Morbidity
  • 3. Measures of Morbidity The WHO expert committee on Health Statistics noted in its 6th report that morbidity could be measured in terms of three units: a) Person who were ill. b) The illness (Periods /spells/illness) that diseased person experience. c) The duration of these illness . Source –WHO(1959)
  • 4. Illness Exist in a given Time Period as follows;  Illness beginning during the period and ending during the period.  Illness beginning during the period and still existing at the end of the period  Illnesses existing before the beginning of the period and ending during the period  Illnesses existing before the beginning of the period and existing at the end of the period (Prakasam 2017) Illness :Time Period
  • 5. Disease , Illness or Sickness is measured by calculating;  Incidence Rate  Prevalence Rate: Period Prevalence Rate, Point Prevalence Rate  Attack Rate , Secondary Attack Rate  Case Fatality Rate  Duration Of illness / Sickness  Relative Risk , Attributable Risk and Odds Ratio Other measures: o Disability Rate o HALE o QALY o DFLE o DALY Measures:
  • 6. Incidence Rate is given by the following equation: Number of new cases of specific, Incidence rate (IR) = 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒏𝒆𝒘 𝒄𝒂𝒔𝒆𝒔 𝒐𝒇 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒄 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝒅𝒖𝒓𝒊𝒏𝒈 𝒂 𝒈𝒊𝒗𝒆𝒏 𝒕𝒊𝒎𝒆 𝒑𝒆𝒓𝒊𝒐𝒅 𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒂𝒕 𝒓𝒊𝒔𝒌 𝒅𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒂𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 × 𝟏𝟎𝟎𝟎 This measure is also discussed in the module on concepts of health. INCIDENT RATE
  • 7. Point Prevalence = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝑐𝑎𝑠𝑒𝑠 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑎𝑡 𝑎 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑠𝑎𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒 Period Prevalence Rate = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝑐𝑎𝑠𝑒𝑠 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑎𝑡 𝑎 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑠𝑎𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 𝑜𝑓 𝑡𝑖𝑚𝑒 PREVALENCE RATE
  • 8. Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 start of illness duration of illness Jan 1 Dec 31 Incidence would be – Point prevalence (Jan 1) – Point prevalence (Dec 31) – Period prevalence (Jan-Dec) – cases 3, 4, 5 and 8 cases 1, 2, 7 cases 1, 3, 5 and 8 cases 1, 2, 3, 4, 5, 7, 8
  • 9. 𝑷 (𝟏−𝑷) =I× 𝑫 Where, P = Proportion of total population with the disease and I is Incidence rate 1-P = Proportion of the total population without the disease In situations where the number of persons with the disease in a population and without the disease are stable, then it is referred to as a steady-state population. In such situations, the point prevalence of the disease (prevalence of the disease at a particular point of time) is approximately equal to the incidence rate X the average duration of the disease. P=I× 𝑫 Relationship between Prevalence and Incident
  • 10. The attack rate the number of new cases of a particular disease during a particular time interval, to the total population at risk of that particular disease in the same period of time, multiplied by 100. It is given by the equation: Attack rate= 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒏𝒆𝒘 𝒄𝒂𝒔𝒆𝒔 𝒐𝒇 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒆𝒅 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 𝒅𝒖𝒓𝒊𝒏𝒈 𝒊𝒕𝒔 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒆𝒅 𝒕𝒊𝒎𝒆 𝒊𝒏𝒕𝒆𝒓𝒗𝒂𝒍 𝑻𝒐𝒕𝒂𝒍 𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒂𝒕 𝒓𝒊𝒔𝒌 𝒅𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒆 𝒔𝒂𝒎𝒆 𝒊𝒏𝒕𝒆𝒓𝒗𝒂𝒍 × 𝟏𝟎𝟎 ATTACK RATE
  • 11. The number of exposed persons developing the disease within the range of the incubation period, following exposure to the primary case” (GOI 2015). The attack rate is based on spells of the disease rather than persons. It is generally used for infections of short period of time as during an epidemic. It usually measures the spread of the infection after exposure to an initial case (Indrayan N.D.). The secondary attack rate is the number of exposed persons developing the disease within the range of the incubation period to the total number of exposed to susceptible contact, multiplied by 100. Secondary Attack Rate = 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒆𝒙𝒑𝒐𝒔𝒆𝒅 𝒑𝒆𝒓𝒔𝒐𝒏𝒔 𝒅𝒆𝒗𝒍𝒐𝒑𝒊𝒏𝒈 𝒕𝒉𝒆 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 𝒘𝒊𝒕𝒉𝒊𝒏 𝒕𝒉𝒆 𝒓𝒂𝒏𝒈𝒆 𝒐𝒇 𝒕𝒉𝒆 𝒊𝒏𝒄𝒖𝒃𝒂𝒕𝒊𝒐𝒏 𝒑𝒆𝒓𝒊𝒐𝒅 𝑻𝒐𝒕𝒂𝒍 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒆𝒙𝒑𝒐𝒔𝒆𝒅 𝒔𝒖𝒔𝒄𝒆𝒑𝒕𝒊𝒃𝒍𝒆 𝒄𝒐𝒏𝒕𝒂𝒄𝒕 ×100 Secondary Attack Rate
  • 12. The duration of illness can be calculated in terms of the average duration of illness per person, per person sick, or spell, and these are expressed by the following equations: Average duration of illness per Person = 𝑻𝒐𝒕𝒂𝒍 𝒅𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 𝑻𝒐𝒕𝒂𝒍 𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒆𝒙𝒑𝒐𝒔𝒆𝒅 Average duration of illness per person sick = 𝑻𝒐𝒕𝒂𝒍 𝑫𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 𝒐𝒇 𝒔𝒊𝒄𝒌 𝒑𝒆𝒓𝒔𝒐𝒏𝒔 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒑𝒆𝒓𝒔𝒐𝒏𝒔 𝒇𝒆𝒍𝒍 𝒊𝒍𝒍 Average duration of illness Per Spell = 𝑻𝒐𝒕𝒂𝒍 𝒅𝒂𝒚𝒔 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 𝒐𝒇 𝒂𝒍𝒍 𝒔𝒊𝒄𝒌 𝒑𝒆𝒓𝒔𝒐𝒏 𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒔𝒑𝒆𝒍𝒍 𝒐𝒇 𝒊𝒍𝒍𝒏𝒆𝒔𝒔 Duration Of ILLNESS
  • 13. RR = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 (𝑜𝑟 𝑑𝑒𝑎𝑡ℎ) 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 (𝑜𝑟 𝑑𝑒𝑎𝑡ℎ) 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛−𝑒𝑥𝑝𝑜𝑠𝑒𝑑 An example of using the Relative Risk, is with a measure of the association between Cancer and smoking. It is given in the table below, wherein those who smoke cigarettes are compared with those who do not smoke cigarettes, in relation to having developed cancer, Relative Risk of those who smoke to get cancer= (a/a+b) = Those who smoke who developed cancer/ the total persons who smoke = 80/4000 x 1000= 2.0 Relative Risk of those who do not smoke to get cancer= (c/c + d ) = Those who do not smoke who developed cancer/ the total number of persons who do not smoke . =6/5000 x 1000= 1.2 Relative Risk (cigarette smoking causes cancer) = (a/a+b) / (c/c + d) = 2.0/1.2 = 1.67 Cigarette Smoking Developed Cancer Not Cancer Total Yes 80(a) 3200(b) 4000( a+b ) NO 6(c) 4994(d) 5000( c+d ) Relative Risk
  • 14.  Relative risk (RR) is a ratio. It directly measures the strength of association between the studied cause and the effect .  If the RR ratio is more than 1, then it suggests a “positive” association.
  • 15. In recent times, there has been no marked change in death rates, and as a result, disability rates as with regard to illness and injury have come to be used in order to supplement the mortality and morbidity indicators. There are two common groups of indicators of disability rates: a) Event type indicators, and b) person type indicators. a) Event-type indicators:  Number of days of restricted activity  Bed disability days  Work-loss days (or school-loss days) within a specified period b) Person-type indicators  Limitation of mobility: Confined to bed, Confine to house  Limitation of activity: Limitation to perform the basic activities of daily living (ADL)- e.g.: eating, washing, dressing, going to toilet, moving around , limitation of doing specific job (Prakasam 2017). Disability Rates:
  • 16. HALE stands for health-adjusted life expectancy. It is based on what was previously the disability-adjusted life expectancy (DALE), changed in order to represent all states of health. The HALE measure is based on life expectancy at birth but is includes an adjustment for time of life spent in poor health. HALE is based on life expectancy at birth but includes an adjustment for time spent in poor health. HALE is the number of years in full health that a newborn can expected to live based on current rate of ill-health and mortality (WHO 2002). HALE is defined as , “ Average number of years that a person can expect to live in "full health" by taking into account years lived in less than full health due to disease and/or injury.” (WHO 2017). The measure takes into account different measures of population health, and it is adjusted for severity distribution, and is sensitive to changes over time and to differences across countries in severity in state of health (WHO 2017). Health-Adjusted Life Expectancy (HALE):
  • 17. QALY or Quality-adjusted life years measures the burden of disease including both quantity of live lives as well as the quality of life lived. It is used to assess a medical intervention in terms of value for money. QALY is thus based on estimating the “number of years of life that would have been lived with perfect life with the medical intervention” (Prieto et.al. 2003). In other words, it can be said to be an indicator that assesses both the quantity and quality of life in the health of a population. Therefore, an extension of life expectancy can also be measured in terms of whether they are years of healthy life. One example is that a person may be taking an intervention to address the problem of hypertension for about 3 decades, which adds a decade more to his life, at a slightly reduced level of quality. He would also need further intervention, which reduces his quality of life further by a given amount. The QALY would then be calculated to see how many years in total would be gained – say, around 8 years after adjusting above. There are many other ways in which QALYs can be applied (uOttawa 2014) Quality-adjusted life years (QALY):
  • 18. There are a few basic facts to DALY mentioned below: 1. DALYs were first reported in the World Development report in 1993 2. DALYs are a new composite indicator of population health status and express the burden of morbidity and mortality. 3. DALYs were designed with cost-effectiveness analysis in mind. DALY measures overall disease burden. It is expressed as the number of years lost due to ill-health, disability or early death. The measure enables capturing the impact of both important fatal and non-fatal disabling conditions on a population. The DALY combines two measures, the Years of Lost Life (YLL) and Years Lost to Disability (YLD) as: ---Years of lost life (YLL): This measure is calculated from the number of deaths occurring at each age, which is multiplied by the expected remaining years of life, according to a global standard of life expectancy. 𝑌𝐿𝐿 = 𝑁 × 𝐿 Where, N=Number of deaths; L= Standard life expectancy at age of death in year DALY: Basic facts;
  • 19. This measure is calculated as the number of incident cases of disability due to injury and illness, multiplied by the average duration of the disease and a weighting factor which reflects disease severity on a scale from 0 (perfect health) to 1 (dead) (Prakasam 2017) YLD=𝐼 × 𝐷𝑊 × 𝐿. Where, I= Number of incidence cases DW = Disability Weight L= average duration of the case until remission or death (years) DALY=𝑌𝐿𝐿 + 𝑌𝐿𝐷 ---Years lost to disability (YLD):
  • 20.  Disability-free life expectancy (DFLE) is the average number of years an individual is expected to live free of disability if the current pattern of mortality and disability continues to apply.  The DFLE indicator has been developed and used in many countries since the 1970s.  The definition is a derivation from statistical sources of organizations as the IMF and OECD. As per the OECD, can be considered in terms of functional limitation-free life expectancy, and activity restriction-free life expectancy (OECD 2003). Disability-free life expectancy (DFLE);
  • 21. Reproductive Morbidity : Apart from the above rates, in the recent period morbidity related to pregnancy and contraception is measured under Reproductive morbidity. Reproductive morbidity: Reproductive morbidities are morbidities that occur during pregnancy, during childbirth or within a period of 42 days of giving birth (Prakasam 2017). WHO (1990) has defined reproductive morbidity broadly as: “any morbidity or dysfunction of the reproductive tract or any morbidity which is a consequence of reproductive behavior including pregnancy, abortion, childbirth or sexual behavior. Morbidities may include those of a psychological nature” The WHO has spelled reproductive morbidity as consisting of three types of morbidity: 1. Obstetric, 2. Gynecological and 3. contraceptive morbidity.
  • 22. Obstetric morbidity: Morbidity in a women who has been pregnant (regardless of the duration of pregnancy) from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. Gynecological morbidity: includes any condition, disease or dysfunction of the reproductive system, which is not related to pregnancy, abortion, or childbirth but may be related to sexual behavior. Contraceptive Morbidity: Contraceptive morbidity includes condition, which result from efforts (other than abortion) to limit family size, whether they are traditional or modern methods” (WHO 1990).
  • 23.  http://www.worldbank.org/html/extdr/hnp/hdddlash/worksp/we_00068.html  http://www.un.org/esa/socdev/enable/dis50y10.htm  http://www.who.int/healthinfo/globalburdendisease/metrics_daly/en/  https://stats.oecd.org/glossary/detail.asp?ID=632  http://mospiold.nic.in/Mospi_New/upload/Manual-Health-Statistics_5june15.pdf  https://books.google.co.in/books?id=GQEdA References